Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 254

1.

Dietary Lectin exclusion: The next big food trend?

Panacer K, Whorwell PJ.

World J Gastroenterol. 2019 Jun 28;25(24):2973-2976. doi: 10.3748/wjg.v25.i24.2973. Review.

2.

Gut-focused hypnotherapy for Functional Gastrointestinal Disorders: Evidence-base, practical aspects, and the Manchester Protocol.

Vasant DH, Whorwell PJ.

Neurogastroenterol Motil. 2019 Aug;31(8):1-12. doi: 10.1111/nmo.13573. Epub 2019 Feb 27. Review.

PMID:
30815936
3.

SKYPE HYPNOTHERAPY FOR IRRITABLE BOWEL SYNDROME: Effectiveness and Comparison with Face-to-Face Treatment.

Hasan SS, Pearson JS, Morris J, Whorwell PJ.

Int J Clin Exp Hypn. 2019 Jan-Mar;67(1):69-80. doi: 10.1080/00207144.2019.1553766.

4.

Availability of over-the-counter laxatives should not be restricted.

Whorwell PJ.

BMJ. 2019 Jan 9;364:l51. doi: 10.1136/bmj.l51. No abstract available.

PMID:
30626628
5.
6.

Efficacy of individual and group hypnotherapy in irritable bowel syndrome (IMAGINE): a multicentre randomised controlled trial.

Flik CE, Laan W, Zuithoff NPA, van Rood YR, Smout AJPM, Weusten BLAM, Whorwell PJ, de Wit NJ.

Lancet Gastroenterol Hepatol. 2019 Jan;4(1):20-31. doi: 10.1016/S2468-1253(18)30310-8. Epub 2018 Nov 23.

PMID:
30473202
7.

Abdominal distension in health and irritable bowel syndrome: The effect of bladder filling.

Issa B, Morris J, Whorwell PJ.

Neurogastroenterol Motil. 2018 Nov;30(11):e13437. doi: 10.1111/nmo.13437. Epub 2018 Aug 1.

PMID:
30070066
8.

The short-term effects of posterior tibial nerve stimulation on anorectal physiology in patients with faecal incontinence: a single centre experience.

Heywood NA, Pearson JS, Nicholson JE, Molyneux C, Sharma A, Kiff ES, Whorwell PJ, Telford KJ.

Therap Adv Gastroenterol. 2018 Jul 1;11:1756284818786111. doi: 10.1177/1756284818786111. eCollection 2018.

9.

Editorial: preventing unnecessary investigation and surgery in the irritable bowel syndrome-the critical role of the general practitioner.

Whorwell PJ.

Aliment Pharmacol Ther. 2018 Jun;47(11):1558-1559. doi: 10.1111/apt.14659. No abstract available.

PMID:
29878437
10.

Minor digestive symptoms and their impact in the general population: a cluster analysis approach.

L'Heureux-Bouron D, Legrain-Raspaud S, Carruthers HR, Whorwell PJ.

Therap Adv Gastroenterol. 2018 Apr 22;11:1756284818768814. doi: 10.1177/1756284818768814. eCollection 2018.

11.

Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.

Pearson JS, Whorwell PJ.

Curr Opin Gastroenterol. 2017 Jan;33(1):21-25. doi: 10.1097/MOG.0000000000000328. Review.

PMID:
28134688
12.

Centrally Mediated Disorders of Gastrointestinal Pain.

Keefer L, Drossman DA, Guthrie E, Simrén M, Tillisch K, Olden K, Whorwell PJ.

Gastroenterology. 2016 Feb 19. pii: S0016-5085(16)00225-0. doi: 10.1053/j.gastro.2016.02.034. [Epub ahead of print]

PMID:
27144628
13.

Cases Report the Cronkhite-Canada Syndrome: Improving the Prognosis.

Yu YQ, Whorwell PJ, Wang LH, Li JX, Chang Q, Meng J.

Medicine (Baltimore). 2015 Dec;94(52):e2356. doi: 10.1097/MD.0000000000002356.

14.

Managing irritable bowel syndrome in primary care.

Corsetti M, Whorwell PJ.

Practitioner. 2015 Jun;259(1783):21-4, 2-3. Review.

PMID:
26455114
15.
16.

Immunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature review.

Pearson JS, Niven RM, Meng J, Atarodi S, Whorwell PJ.

Therap Adv Gastroenterol. 2015 Sep;8(5):270-7. doi: 10.1177/1756283X15588875. Review.

17.

The continuing dilemma of chronic appendicitis.

Whorwell PJ.

Therap Adv Gastroenterol. 2015 May;8(3):112-3. doi: 10.1177/1756283X15576463. No abstract available.

18.

Letter: efficacy of hypnotherapy in one thousand patients with irritable bowel syndrome--authors' reply.

Miller V, Carruthers H, Morris J, Hasan SS, Archbold S, Whorwell PJ.

Aliment Pharmacol Ther. 2015 Jun;41(11):1223-4. doi: 10.1111/apt.13205. No abstract available.

19.

Modulation of human visceral sensitivity by noninvasive magnetoelectrical neural stimulation in health and irritable bowel syndrome.

Algladi T, Harris M, Whorwell PJ, Paine P, Hamdy S.

Pain. 2015 Jul;156(7):1348-56. doi: 10.1097/j.pain.0000000000000187.

PMID:
25867123
20.

The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.

Chassany O, Tugaut B, Marrel A, Guyonnet D, Arbuckle R, Duracinsky M, Whorwell PJ, Azpiroz F.

Neurogastroenterol Motil. 2015 Jun;27(6):885-98. doi: 10.1111/nmo.12565. Epub 2015 Apr 6.

PMID:
25846412
21.

Hypnotherapy for irritable bowel syndrome: an audit of one thousand adult patients.

Miller V, Carruthers HR, Morris J, Hasan SS, Archbold S, Whorwell PJ.

Aliment Pharmacol Ther. 2015 May;41(9):844-55. doi: 10.1111/apt.13145. Epub 2015 Mar 4.

22.

In the performing art of medicine: the doctor as actor.

Whorwell PJ, Shanahan F.

QJM. 2016 Mar;109(3):159-60. doi: 10.1093/qjmed/hcv053. Epub 2015 Feb 24. No abstract available.

PMID:
25715877
23.

IBS in 2014: Developments in pathophysiology, diagnosis and management.

Whorwell PJ.

Nat Rev Gastroenterol Hepatol. 2015 Feb;12(2):72-4. doi: 10.1038/nrgastro.2014.225. Epub 2014 Dec 23. Review. No abstract available.

PMID:
25534505
24.

Using pictures to improve communication between doctor and patient in functional gastrointestinal disorders.

Carruthers HR, Whorwell PJ.

Aliment Pharmacol Ther. 2014 Dec;40(11-12):1364. doi: 10.1111/apt.12962. No abstract available.

25.

Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?

Pearson JS, Pollard C, Whorwell PJ.

Therap Adv Gastroenterol. 2014 Nov;7(6):232-7. doi: 10.1177/1756283X14540028.

26.

Changes of the human gut microbiome induced by a fermented milk product.

Veiga P, Pons N, Agrawal A, Oozeer R, Guyonnet D, Brazeilles R, Faurie JM, van Hylckama Vlieg JE, Houghton LA, Whorwell PJ, Ehrlich SD, Kennedy SP.

Sci Rep. 2014 Sep 11;4:6328. doi: 10.1038/srep06328.

27.

Conducting multinational, cross-cultural research in the functional gastrointestinal disorders: issues and recommendations. A Rome Foundation working team report.

Sperber AD, Gwee KA, Hungin AP, Corazziari E, Fukudo S, Gerson C, Ghoshal UC, Kang JY, Levy RL, Schmulson M, Dumitrascu D, Gerson MJ, Chen M, Myung SJ, Quigley EM, Whorwell PJ, Zarzar K, Whitehead WE.

Aliment Pharmacol Ther. 2014 Nov;40(9):1094-102. doi: 10.1111/apt.12942. Epub 2014 Sep 1. Review.

28.

Irritable bowel syndrome: the problem and the problem of treating it - is there a role for probiotics?

Santos AR, Whorwell PJ.

Proc Nutr Soc. 2014 Nov;73(4):470-6. doi: 10.1017/S0029665114000706. Epub 2014 Aug 26. Review.

PMID:
25156472
29.

Irritable bowel syndrome: a comparison of subtypes.

Rey de Castro NG, Miller V, Carruthers HR, Whorwell PJ.

J Gastroenterol Hepatol. 2015 Feb;30(2):279-85. doi: 10.1111/jgh.12704.

PMID:
25091059
30.

Faecal incontinence-the hidden scourge of irritable bowel syndrome: a cross-sectional study.

Atarodi S, Rafieian S, Whorwell PJ.

BMJ Open Gastroenterol. 2015 Feb 6;1(1):e000002. doi: 10.1136/bmjgast-2014-000002. eCollection 2014.

31.

The Manchester Colour Wheel: enhancing its utility.

Carruthers HR, Whorwell PJ.

Percept Mot Skills. 2013 Jun;116(3):761-72.

PMID:
24175451
32.

Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.

Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA.

Gastroenterology. 2013 Oct;145(4):749-57; quiz e13-4. doi: 10.1053/j.gastro.2013.07.014. Epub 2013 Jul 19.

PMID:
23872499
33.

Hypnotherapy: first line treatment for children with irritable bowel syndrome?

Whorwell PJ.

Arch Dis Child. 2013 Apr;98(4):243-4. doi: 10.1136/archdischild-2012-303178. Epub 2013 Mar 2. No abstract available.

PMID:
23456974
34.

What is irritable bowel syndrome?

Whorwell PJ.

Therap Adv Gastroenterol. 2012 Nov;5(6):379-80. doi: 10.1177/1756283X12461061. No abstract available.

35.

Refractory inflammatory bowel disease-could it be an irritable bowel?

Meng J, Agrawal A, Whorwell PJ.

Nat Rev Gastroenterol Hepatol. 2013 Jan;10(1):58-61. doi: 10.1038/nrgastro.2012.173. Epub 2012 Sep 11. Review.

PMID:
22965430
36.

The Manchester Color Wheel: validation in secondary school pupils.

Carruthers HR, Magee L, Osborne S, Hall LK, Whorwell PJ.

BMC Med Res Methodol. 2012 Sep 5;12:136. doi: 10.1186/1471-2288-12-136.

37.

Intestinal microbiota in functional bowel disorders: a Rome foundation report.

Simrén M, Barbara G, Flint HJ, Spiegel BM, Spiller RC, Vanner S, Verdu EF, Whorwell PJ, Zoetendal EG; Rome Foundation Committee.

Gut. 2013 Jan;62(1):159-76. doi: 10.1136/gutjnl-2012-302167. Epub 2012 Jun 22.

38.

Identifying and testing candidate genetic polymorphisms in the irritable bowel syndrome (IBS): association with TNFSF15 and TNFα.

Swan C, Duroudier NP, Campbell E, Zaitoun A, Hastings M, Dukes GE, Cox J, Kelly FM, Wilde J, Lennon MG, Neal KR, Whorwell PJ, Hall IP, Spiller RC.

Gut. 2013 Jul;62(7):985-94. doi: 10.1136/gutjnl-2011-301213. Epub 2012 Jun 8.

PMID:
22684480
39.

Unraveling functional abdominal bloating and distension: the role of thoraco-abdominal accommodation and a physical sign to aid its detection.

Whorwell PJ.

Neurogastroenterol Motil. 2012 Apr;24(4):301-4. doi: 10.1111/j.1365-2982.2012.01896.x.

PMID:
22414185
40.

Synesthesia, pseudo-synesthesia, and irritable bowel syndrome.

Carruthers HR, Miller V, Tarrier N, Whorwell PJ.

Dig Dis Sci. 2012 Jun;57(6):1629-35. doi: 10.1007/s10620-012-2054-2.

PMID:
22290344
41.

A randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).

Flik CE, van Rood YR, Laan W, Smout AJ, Weusten BL, Whorwell PJ, de Wit NJ.

BMC Gastroenterol. 2011 Dec 20;11:137. doi: 10.1186/1471-230X-11-137.

42.

IBS: Hypnotherapy--a wasted resource?

Whorwell PJ.

Nat Rev Gastroenterol Hepatol. 2011 Dec 6;9(1):12-3. doi: 10.1038/nrgastro.2011.235. No abstract available.

PMID:
22143271
44.

Tackling conflicts of interest. Collaboration with industry facilitates useful research that wouldn't happen otherwise.

Whorwell PJ.

BMJ. 2011 Sep 6;343:d5612. doi: 10.1136/bmj.d5612. No abstract available.

PMID:
21896593
45.

Visceral hypersensitivity in endometriosis: a new target for treatment?

Issa B, Onon TS, Agrawal A, Shekhar C, Morris J, Hamdy S, Whorwell PJ.

Gut. 2012 Mar;61(3):367-72. doi: 10.1136/gutjnl-2011-300306. Epub 2011 Aug 25.

PMID:
21868492
46.

Abdominal bloating and distension: what is the role of the microbiota.

Issa B, Wafaei NA, Whorwell PJ.

Dig Dis Sci. 2012 Jan;57(1):4-8. doi: 10.1007/s10620-011-1834-4. Epub 2011 Jul 29. Review.

PMID:
21800157
47.

Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndrome.

Carruthers HR, Morris J, Tarrier N, Whorwell PJ.

BMC Complement Altern Med. 2010 Dec 7;10:75. doi: 10.1186/1472-6882-10-75.

48.

The Patient Health Questionnaire 12 Somatic Symptom scale as a predictor of symptom severity and consulting behaviour in patients with irritable bowel syndrome and symptomatic diverticular disease.

Spiller RC, Humes DJ, Campbell E, Hastings M, Neal KR, Dukes GE, Whorwell PJ.

Aliment Pharmacol Ther. 2010 Sep;32(6):811-20. doi: 10.1111/j.1365-2036.2010.04402.x.

49.

The Manchester Color Wheel: development of a novel way of identifying color choice and its validation in healthy, anxious and depressed individuals.

Carruthers HR, Morris J, Tarrier N, Whorwell PJ.

BMC Med Res Methodol. 2010 Feb 9;10:12. doi: 10.1186/1471-2288-10-12.

50.

Emerging drugs for irritable bowel syndrome.

Shekhar C, Whorwell PJ.

Expert Opin Emerg Drugs. 2009 Dec;14(4):673-85. doi: 10.1517/14728210903222279. Review.

PMID:
19939211

Supplemental Content

Loading ...
Support Center